1. Pfizer says coronavirus vaccine study shows mostly mild-to-moderate side effects  Reuters
  2. China Covid-19 vaccine may be ready for public in November, say officials  FRANCE 24 English
  3. BioNTech wins $445 million German grant for COVID-19 vaccine  Yahoo Finance
  4. In coronavirus vaccine race, China inoculates thousands before trials are completed  Reuters
  5. Pfizer Says Late-stage Coronavirus Vaccine Study Shows Moderate Side Effects  News18
  6. View Full coverage on Google News

Pfizer says coronavirus vaccine study shows mostly mild-to-moderate side effects

Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.

China Covid-19 vaccine may be ready for public in November, say officials

German biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany. BioNTech and partners Pfizer Inc and China's Shanghai Fosun Pharmaceutical Group Co Ltd are amongGerman biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany. BioNTech and partners Pfizer Inc and China's Shanghai Fosun Pharmaceutical Group Co Ltd are among

BioNTech wins $445 million German grant for COVID-19 vaccine

Pfizer Inc said on Tuesday participants were showing mildtomoderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing latestage study.Pfizer Inc said on Tuesday participants were showing mildtomoderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing latestage study.

Pfizer Says Late-stage Coronavirus Vaccine Study Shows Moderate Side Effects

Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.

China coronavirus vaccine may be ready for public in November: official - Citizentv.co.ke

DUBAI, Sept 15 — The United Arab Emirates yesterday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started. A phase III trial of a Covid-19 inactivated vaccine developed by Chinese state-owned pharmaceutical company Sinopham began...DUBAI, Sept 15 — The United Arab Emirates yesterday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started. A phase III trial of a Covid-19 inactivated vaccine developed by Chinese state-owned pharmaceutical company Sinopham began...

UAE announces emergency approval for use of Covid-19 vaccine | World | Malay Mail

Pfizer is among the stocks driving the rally in US futures after CEO's optimistic announcement over vaccine.Pfizer is among the stocks driving the rally in US futures after CEO's optimistic announcement over vaccine.

Pfizer stock rockets as potential COVID-19 vaccine delivery by end of 2020